Auto-generated event page

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today ann...

Score 41 low confidence 1 source posts Updated Mar 4, 2026, 9:05 PM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire Public Companies • Mar 4, 2026, 9:01 PM UTC

Entity focus

Direct link to post

https://pushme.site/signals/193053-syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-ru?utm_source=signal-193053&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub